5 results on '"Stridsberg M"'
Search Results
2. High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours
- Author
-
Welin, SV, primary, Janson, ET, additional, Sundin, A, additional, Stridsberg, M, additional, Lavenius, E, additional, Granberg, D, additional, Skogseid, B, additional, Oberg, KE, additional, and Eriksson, BK, additional
- Published
- 2004
- Full Text
- View/download PDF
3. Obestatin/ghrelin cells in normal mucosa and endocrine tumours of the stomach.
- Author
-
Tsolakis AV, Grimelius L, Stridsberg M, Falkmer SE, Waldum HL, Saras J, and Janson ET
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoid Tumor, Female, Ghrelin analysis, Ghrelin blood, Humans, Immunohistochemistry, In Vitro Techniques, Male, Middle Aged, Radioimmunoassay, Vesicular Monoamine Transport Proteins analysis, Vesicular Monoamine Transport Proteins metabolism, Endocrine Gland Neoplasms metabolism, Gastric Mucosa metabolism, Gene Expression Regulation, Neoplastic, Ghrelin metabolism, Stomach Neoplasms metabolism
- Abstract
Objective: Obestatin and ghrelin are derived from the same gene and co-expressed in the same endocrine cells. Vesicular monoamine transporter-2 (VMAT-2), a marker for enterochromaffin-like (ECL) cells, is considered to be expressed in ghrelin cells. The aim was to establish if the two peptides and the transporter are co-expressed, both in normal gastric mucosa and in gastric endocrine tumours., Design: An immunohistochemical study was performed on gastric biopsy material and on surgical specimens from 63 patients with gastric endocrine tumours and from individuals with normal gastric mucosa. Cells displaying obestatin immunoreactivity were examined regarding co-localization with ghrelin and VMAT-2. Both single- and double-immunostaining techniques were applied. Obestatin concentration in blood was measured in a subgroup of these patients. The results were correlated to various clinico-pathological parameters., Results: In the normal mucosa, obestatin/ghrelin-immunoreactive cells rarely co-expressed VMAT-2. In most tumour tissue specimens, only a fraction of neoplastic cells displayed immunoreactivity to obestatin, and these cells always co-expressed ghrelin. Neoplastic obestatin-/ghrelin-IR cells invariably expressed VMAT-2, except for two ghrelinomas. The obestatin concentrations in blood were consistently low and did not correlate to clinico-pathological data., Conclusions: Obestatin and ghrelin immunoreactivity always occurred in the same endocrine cells in the gastric mucosa but these cells only occasionally co-expressed VMAT-2, opposite to the findings in tumours. These results indicate that endocrine cells expressing obestatin and ghrelin mainly differ from VMAT-2 expressing cells (ECL-cells) and can develop into pure ghrelinomas. Plasma concentrations of obestatin did not correlate to cellular expression.
- Published
- 2009
- Full Text
- View/download PDF
4. Tachykinins in endocrine tumors and the carcinoid syndrome.
- Author
-
Cunningham JL, Janson ET, Agarwal S, Grimelius L, and Stridsberg M
- Subjects
- Amino Acid Sequence, Antibody Specificity, Biomarkers, Tumor metabolism, Endocrine Gland Neoplasms blood, Humans, Malignant Carcinoid Syndrome blood, Molecular Sequence Data, Retrospective Studies, Sequence Homology, Tachykinins blood, Tachykinins immunology, Endocrine Gland Neoplasms metabolism, Malignant Carcinoid Syndrome metabolism, Tachykinins metabolism
- Abstract
Objective: A new antibody, active against the common tachykinin (TK) C-terminal, was used to study TK expression in patients with endocrine tumors and a possible association between plasma-TK levels and symptoms of diarrhea and flush in patients with metastasizing ileocecal serotonin-producing carcinoid tumors (MSPCs)., Method: TK, serotonin and chromogranin A (CgA) immunoreactivity (IR) was studied by immunohistochemistry in tissue samples from 33 midgut carcinoids and 72 other endocrine tumors. Circulating TK (P-TK) and urinary-5 hydroxyindoleacetic acid (U-5HIAA) concentrations were measured in 42 patients with MSPCs before treatment and related to symptoms in patients with the carcinoid syndrome. Circulating CgA concentrations were also measured in 39 out of the 42 patients., Results: All MSPCs displayed serotonin and strong TK expression. TK-IR was also seen in all serotonin-producing lung and appendix carcinoids. None of the other tumors examined contained TK-IR cells. Concentrations of P-TK, P-CgA, and U-5HIAA were elevated in patients experiencing daily episodes of either flush or diarrhea, when compared with patients experiencing occasional or none of these symptoms. In a Spearman partial rank test, the correlation of P-TK with daily diarrhea was independent of both U-5HIAA and CgA levels., Conclusion: We found that TK synthesis occurs in serotonin-IR tumors and that P-TK levels are significantly correlated with symptoms of flush and diarrhea in patients with MSPCs. This is, to our knowledge, the first report demonstrating an independent correlation of P-TKs with carcinoid diarrhea, a symptom that is customarily regarded as serotonin mediated. Further investigations may present opportunities for new therapeutic possibilities.
- Published
- 2008
- Full Text
- View/download PDF
5. Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma.
- Author
-
Stridsberg M and Husebye ES
- Subjects
- Adolescent, Adrenal Gland Neoplasms blood, Adrenal Gland Neoplasms surgery, Adult, Aged, Catecholamines metabolism, Catecholamines urine, Chromogranin A, Chromogranin B, Creatinine blood, Female, Humans, Immunohistochemistry, Male, Middle Aged, Neuropeptide Y blood, Neuropeptide Y metabolism, Pancreatic Hormones blood, Pancreatic Hormones metabolism, Paraganglioma diagnosis, Pheochromocytoma blood, Pheochromocytoma surgery, Prognosis, Adrenal Gland Neoplasms diagnosis, Biomarkers, Tumor blood, Chromogranins blood, Pheochromocytoma diagnosis, Proteins
- Abstract
Specific assays for measurements of circulating chromogranin (Cg) A, CgB, CgC and pancreastatin (Ps) have recently been developed. The aim of the present study was to investigate the usefulness of these markers in diagnosing and following the effects of treatment of patients with phaeochromocytoma, and to compare the results with those concerning other biochemical markers. CgA was elevated in 19/21 (90%), CgB in 17/21 (81%), Ps in 9/21 (43%) and neuropeptide Y in 9/21 (43%) of the patients. Urinary noradrenaline was increased in 19/21 (90%) and urinary adrenaline in 17/19 (89%) of the patients. All patients had increased levels of either urinary catecholamines or plasma chromogranins. In one patient levels of CgA, CgB and Ps were measured at frequent intervals before, during and after surgery. The CgA level fell to normal shortly after the tumour was removed, whereas the CgB level decreased towards normal over the course of several days. Significant correlation was observed between the contents of CgA and CgB in the tumour tissue and the plasma levels of CgA and CgB respectively. We conclude that CgA and CgB are sensitive circulating markers for phaeochromocytoma and that measurements of both urinary catecholamines and plasma chromogranins improve the diagnostic sensitivity. Furthermore, measurements of CgA may be useful in assessing the radicality of surgery in the early postoperative period.
- Published
- 1997
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.